CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T CellsMatthias Braun, Tobias Bald, Ashmitha Sundarrajan et al.|Immunity|2020Cited by 181